Both in Biotechnology
Curis vs Liminatus Pharma
Over the past year CRIS returned −98.5% and LIMN returned −95.9%; their daily moves had a correlation of 0.02.
CRIS −98.5% LIMN −95.9%Growth of $1, one year, split-adjusted
| Metric | CRIS | LIMN |
|---|---|---|
| Price | $0.4540 | $2.92 |
| Market cap | $1.1M | $3.9M |
| Today | +12.79% | +1.04% |
| 1 month | −45.2% | −25.3% |
| 6 months | −96.0% | −71.4% |
| Year to date | −97.7% | −90.4% |
| 1 year | −98.5% | −95.4% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $5.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 133.3% | 1,152.8% |
| Short % of float | 23.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).